BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice
Download
Download
DownloadPreview
fpsyg-07-02063.pdf
- Published Version
(332kB)
| Preview
Available under license: Creative Commons Attribution
Export
Sorensen, James, Petersen, Aaron 
ORCID: 0000-0003-1508-748X, Timpani, Cara ORCID: 0000-0003-4567-4319, Campelj, Dean G, Cook, Jordan, Trewin, Adam, Stojanovska, Vanesa, Stewart, Mathew, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036
(2017)
BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice.
Frontiers in Pharmacology, 8.
ISSN 1663-9812
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/33163 |
| DOI | 10.3389/fphar.2017.00137 |
| Official URL | http://journal.frontiersin.org/article/10.3389/fph... |
| Subjects | Historical > FOR Classification > 1116 Medical Physiology Historical > Faculty/School/Research Centre/Department > Institute of Sport, Exercise and Active Living (ISEAL) Historical > Faculty/School/Research Centre/Department > Institute for Sustainability and Innovation (ISI) Current > Division/Research > College of Health and Biomedicine |
| Keywords | skeletal muscle; oxaliplatin chemotherapy; BGP-15; mitochondria; protein synthesis; muscle wasting; mitochondrial reactive oxygen species |
| Citations in Scopus | 27 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)